We are monitoring the impact of COVID-19 on APAC High Potency APIs (HPAPI) Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2904
Share on
Share on

Asia Pacific High Potency APIs (HPAPI) Research Report – Segmented By Type, Synthesis, Therapeutic Application & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: February, 2020
ID: 2904
Pages: 145

APAC High Potency APIs (HPAPI) Market Size & Growth (2019 - 2024)

Asia Pacific High Potency APIs (HPAPI) Market size was valued at USD 4.14 billion in 2019 and estimated to be growing at a CAGR of 9.1%, to reach USD 6.39 billion by 2024 during the forecast period 2019-2024.

High Potency Active Pharmaceutical Ingredients (HPAPI) are a group of pharmacological substances and intermediates, active at concentrations of 150 micrograms per kilogram of body weight or below. They are characterized by high specificity, so they can bind to specific receptors or to specific enzymes which can cause cancer, reproductive problems, and developmental disorders at low doses. The growth of this market is high as many new drugs have these HPAPI’s.

High Potency Active Pharmaceutical Ingredients gave rise to alternative methods of treatment by different drugs, notably cancer. After the human genome mapping, new drugs for cancer could be made not only for different cancers but also for different patients. Their production is to be done with great care since they are active even at low concentrations. They can pose grave consequences to workers if proper care is not taken during production. Special care has to be taken to prevent contamination of drugs with contaminants. So it requires specialized equipment for handling HPAPI’s and managing air quality.

The Asia-Pacific High Potency Active Pharmaceutical Ingredients market has driving factors such as low price, growing government initiatives to increase the usage of generic medicines to cut down healthcare costs, growing healthcare prices, rising number of pharmaceutical manufacturers and patients.

However, the market is constrained by factors like lack of skilled workers, stringent regulatory requirements and the high price of equipment.

This research report has been segmented and sub-segmented into the following categories:

  • By Type: Innovative HPAPI's and Generic HPAPI's.
  • By Synthesis: Biotech HPAPI's and Synthetic HPAPI's.
  • By Therapeutic Application: Oncology, Glaucoma and Hormonal Balance.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.

This region is expected to be the fastest-growing region in the world. Factors such as increased funding into cancer research, the rising number of people diagnosed with cancer and approval for the production of new drugs are going to boost the growth of this market in the region.

Promising companies leading the APAC High Potency API (HPAPI) Market Profiled in the Report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction                           

               1.1 Market Definition              

               1.2 Study Deliverables             

               1.3 Base Currency, Base Year and Forecast Periods                     

               1.4 General Study Assumptions            

2. Research Methodology

               2.1 Introduction         

               2.2 Research Phases                

                              2.2.1 Secondary Research      

                              2.2.2 Primary Research                                

                              2.2.3 Econometric Modelling

                              2.2.4 Expert Validation                                 

               2.3 Analysis Design                   

               2.4 Study Timeline                    

3. Overview                               

               3.1 Executive Summary           

               3.2 Key Inferences                    

               3.3 Epidemology                       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                  

               4.1 Market Drivers                   

               4.2 Market Restraints              

               4.3 Key Challenges                   

               4.4 Current Opportunities in the Market           

5. Market Segmentation                        

               5.1 Type                       

                              5.1.1 Innovative HPAPI's                              

                              5.1.2 Generic HPAPI's                                   

                              5.1.3  Y-o-Y Growth Analysis, By Type

                              5.1.4  Market Attractiveness Analysis, By Type

                              5.1.5  Market Share Analysis, By Type

               5.2 Synthesis               

                              5.2.1 Biotech HPAPI's                                   

         5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type               

                        5.2.1.1.1 Innovative Biotech HPAPIs         

                        5.2.1.1.2 Biosimilars       

                              5.2.2 Synthetic HPAPI's                                

         5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type              

                        5.2.2.1.1 Innovative Synthetic HPAPIs      

                        5.2.2.1.2 Generic Synthetic HPAPIs           

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis        

                              5.2.4 Market Attractiveness Analysis, By Synthesis        

                              5.2.5 Market Share Analysis, By Synthesis        

               5.3 Therapeutic Application                  

                              5.3.1 Oncology                               

                              5.3.2 Glaucoma                              

                              5.3.3 Hormonal Balance                              

                              5.3.4 Other therapeutic applications  

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                                 

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                               

                              5.3.7  Market Share Analysis, By Therapeutic Application                                

               5.4 Manufacturer                     

                              5.4.1 Captive Manufacturers 

                              5.4.2 Merchant Manufacturers                                 

         5.4.2.1 Merchant HPAPI Manufacturers Market, By Type                 

                        5.4.2.1.1 Innovative Merchant HPAPI Manufacturers         

                        5.4.2.1.2 Generic Merchant HPAPI Manufacturers              

         5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                             

                        5.4.2.2.1 Synthetic HPAPIs           

                        5.4.2.2.2 Biotech HPAPIs              

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer

                              5.4.4  Market Attractiveness Analysis, By Manufacturer                                  

                              5.4.5  Market Share Analysis, By Manufacturer                                   

6. Geographical Analysis                        

               6.1 Introduction         

                              6.1.1 Regional Trends                                   

                              6.1.2 Impact Analysis

                              6.1.3 Y-o-Y Growth Analysis   

         6.1.3.1 By Type                

         6.1.3.2 By Synthesis                       

         6.1.3.3 By Therapeutic Application                           

         6.1.3.4 By Manufacturer               

                              6.1.4  Market Attractiveness Analysis 

         6.1.4.1 By Type                

         6.1.4.2 By Synthesis                       

         6.1.4.3 By Therapeutic Application                           

         6.1.4.4  By Manufacturer                             

                              6.1.5  Market Share Analysis  

         6.1.5.1 By Type                

         6.1.5.2 By Synthesis                       

         6.1.5.3 By Therapeutic Application                           

         6.1.5.4 By Manufacturer               

               6.2 China                     

               6.3 India                      

               6.4 Japan                     

               6.5 South Korea         

               6.6 Australia               

7.Strategic Analysis                                 

               7.1 PESTLE analysis                  

                              7.1.1 Political                                  

                              7.1.2 Economic                               

                              7.1.3 Social  

                              7.1.4 Technological  

                              7.1.5 Legal   

                              7.1.6 Environmental 

               7.2 Porter’s Five analysis        

                              7.2.1 Bargaining Power of Suppliers   

                              7.2.2 Bargaining Power of Consumers                                   

                              7.2.3 Threat of New Entrants

                              7.2.4 Threat of Substitute Products and Services                                

                              7.2.5 Competitive Rivalry within the Industry  

8.Market Leaders' Analysis                                   

               8.1 Pfizer Inc.             

                              8.1.1 Overview                                

                              8.1.2 Product Analysis                                  

                              8.1.3 Financial analysis                                 

                              8.1.4 Recent Developments   

                              8.1.5 SWOT analysis 

                              8.1.6 Analyst View     

               8.2 Novartis International AG               

               8.3 Sanofi                    

               8.4 F. Hoffmann-La Roche Ltd.            

               8.5 Eli Lilly and Company                       

               8.6 Bristol-Myers Squibb                        

               8.7 Boehringer Ingelheim                      

               8.8 Teva Pharmaceutical Industries Ltd.            

               8.9 Merck & Co., Inc.               

               8.10 AbbVie Inc.                        

               8.11 Mylan Inc.          

9.Competitive Landscape 

               9.1 Market share analysis                      

               9.2 Merger and Acquisition Analysis                   

               9.3 Agreements, collaborations and Joint Ventures                     

               9.4 New Product Launches                    

10.Market Outlook and Investment Opportunities  

Appendix

               a) List of Tables          

               b) List of Figures        

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Innovative HPAPI's  Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Generic HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Biotech HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Synthetic HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  7. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  8. Asia-Pacific Oncology Market By Region, From 2019-2024 ( USD Billion )
  9. Asia-Pacific Glaucoma Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Hormonal Balance Market By Region, From 2019-2024 ( USD Billion )
  11. Asia-Pacific other therapeutic applications Market By Region, From 2019-2024 ( USD Billion )
  12. Japan High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  13. Japan High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  14. Japan High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  15. China High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  16. China High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  17. China High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  18. India High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  19. India High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  20. India High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  21. Australia High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  22. Australia High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  23. Australia High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  24. South Korea High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  25. South Korea High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  26. South Korea High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample